Publications by authors named "S Olschwang"

Claim this Profile
P
Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial.
Bernadette de Rauglaudre, Camille Sibertin-Blanc, Aurélie Fabre, Karine Le Malicot, Jaafar Bennouna, Sylviane Olschwang

Ther Adv Med Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of P53-mediated cell cycle control as the determinant in dedifferentiated liposarcomas development.
Mossane Stocker, Louis-Romée Le Nail, Hubert De Belenet, Jay S Wunder, Irene L Andrulis, Sylviane Olschwang

Am J Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing.
Pascal Pujol, Massimo Barberis, Philp Beer, Eitan Friedman, Josep M Piulats, Sylviane Olschwang

Eur J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of heterozygous variants in French patients with Lynch syndrome.
Qing Wang, Julie Leclerc, Gaëlle Bougeard, Sylviane Olschwang, Stéphanie Vasseur

J Med Genet· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile.
Jean Camille Mattei, Corinne Bouvier-Labit, Doriane Barets, Nicolas Macagno, Mathieu Chocry, Sylviane Olschwang

Cancers (Basel)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis